Variant report
Variant | esv11873 |
---|---|
Chromosome Location | chr2:21611318-21612150 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:21609330..21611613-chr2:21622342..21624204,2 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs563496976 | chr2:21611321-21611322 | ZNF genes & repeats Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs529469348 | chr2:21611337-21611338 | ZNF genes & repeats Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs374704541 | chr2:21611346-21611347 | ZNF genes & repeats Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs77240354 | chr2:21611365-21611366 | ZNF genes & repeats Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs12616733 | chr2:21611378-21611379 | ZNF genes & repeats Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs11125982 | chr2:21611403-21611404 | ZNF genes & repeats Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs551750031 | chr2:21611422-21611423 | ZNF genes & repeats Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs571593667 | chr2:21611449-21611450 | ZNF genes & repeats Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs76028349 | chr2:21611509-21611510 | ZNF genes & repeats Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs73919233 | chr2:21611529-21611530 | ZNF genes & repeats Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs11125983 | chr2:21611530-21611531 | ZNF genes & repeats Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs536434601 | chr2:21611545-21611546 | ZNF genes & repeats Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs149154030 | chr2:21611572-21611573 | ZNF genes & repeats Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs573087582 | chr2:21611579-21611580 | ZNF genes & repeats Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs545013489 | chr2:21611593-21611594 | ZNF genes & repeats Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs558484836 | chr2:21611609-21611610 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
17 | rs372349579 | chr2:21611661-21611662 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
18 | rs12614275 | chr2:21611734-21611735 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
19 | rs575137944 | chr2:21611741-21611742 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
20 | rs57680959 | chr2:21611765-21611766 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
21 | rs202052455 | chr2:21611767-21611768 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
22 | rs386643913 | chr2:21611769-21611770 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
23 | rs66949321 | chr2:21611770-21611771 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
24 | rs143552255 | chr2:21611869-21611870 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs529773738 | chr2:21611873-21611874 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs111952132 | chr2:21611889-21611890 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs17042250 | chr2:21611910-21611911 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
28 | rs528773088 | chr2:21611922-21611923 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs138156599 | chr2:21611951-21611952 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs72910120 | chr2:21611983-21611984 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs530942349 | chr2:21611989-21611990 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs186563120 | chr2:21612020-21612021 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs567738429 | chr2:21612094-21612095 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs6717828 | chr2:21612150-21612151 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 16751803 | CNVD |
Neuroblastoma | 16790693 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 17393978 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Ependymoma | 16718352 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Bladder cancer | 21909424 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Neuroblastoma | 19638189 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Neuroblastoma | 18574593 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Medulloblastoma | 22160402 | CNVD |
Schizophrenia | 22118685 | CNVD |
Epilepsy | 22118685 | CNVD |
Breast cancer | 21509527 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 19521722 | CNVD |
Autism | 18522746 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Ovarian cancer | 17908972 | CNVD |
Neurocytoma | 17123091 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Neuroblastoma | 18765546 | CNVD |
Neuroblastoma | 18281664 | CNVD |
Neuroblastoma | 17289879 | CNVD |
Neuroblastoma | 19738985 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:21582000-21634600 | Weak transcription | Aorta | Aorta |
2 | chr2:21611200-21611800 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr2:21611400-21611600 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
4 | chr2:21611400-21611600 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
5 | chr2:21611400-21611600 | Bivalent Enhancer | Foreskin Melanocyte Primary Cells skin01 | Skin |
6 | chr2:21611600-21612800 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |